Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,282 | -56,671 | -27,319 | -21,873 | -14,526 |
| Depreciation Amortization | 7,819 | 2,360 | 741 | 825 | 551 |
| Accounts receivable | 81 | 26 | 17 | -9 | -79 |
| Other Working Capital | -2,695 | 6,960 | -1,866 | 2,364 | -2,171 |
| Other Operating Activity | 8,257 | 8,214 | 5,772 | 5,679 | 5,802 |
| Operating Cash Flow | $-62,820 | $-39,111 | $-22,655 | $-13,014 | $-10,423 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 66,484 | -65,592 | N/A | 0 | N/A |
| PPE Investments | -6,309 | -9,243 | -860 | -519 | 3,389 |
| Net Acquisitions | -199 | -10,251 | N/A | N/A | N/A |
| Investing Cash Flow | $59,976 | $-85,086 | $-860 | $-519 | $3,389 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -400 |
| Common Stock Issued | 113,902 | 5,477 | 92,403 | 42,387 | 36,052 |
| Common Stock Repurchased | N/A | N/A | N/A | 150 | N/A |
| Financing Cash Flow | $113,902 | $5,477 | $92,403 | $42,537 | $35,652 |
| Beginning Cash Position | 19,310 | 138,030 | 69,142 | 40,138 | 11,520 |
| End Cash Position | 130,368 | 19,310 | 138,030 | 69,142 | 40,138 |
| Net Cash Flow | $111,058 | $-118,720 | $68,888 | $29,004 | $28,618 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,820 | -39,111 | -22,655 | -13,014 | -10,423 |
| Capital Expenditure | -6,309 | -9,243 | -860 | -519 | -308 |
| Free Cash Flow | -69,129 | -48,354 | -23,515 | -13,533 | -10,731 |